Sign In
Buy SLNO
$53.01
+0 (+0%)
At Close: Jun 23, 2026
Recent Price Trend in Soleno Therapeutics (SLNO) is Your Friend, Here's Why
09:50am, Wednesday, 09'th Oct 2024
If you are looking for stocks that are well positioned to maintain their recent uptrend, Soleno Therapeutics (SLNO) could be a great choice. It is one of the several stocks that passed through our "Re
SLNO Stock Rises as Prader-Willi Treatment Nears FDA Approval
06:51pm, Tuesday, 08'th Oct 2024
Soleno Therapeutics (SLNO, Financial) experienced a notable stock price increase of 9.11% following positive developments in its regulatory process. This performance far exceeded that of the S&P 500 i
Why Soleno Therapeutics Stock Blasted 9% Higher Today
06:29pm, Tuesday, 08'th Oct 2024
The company's Prader-Willi treatment inched closer to FDA approval.
Janus Henderson Group PLC's Strategic Acquisition in Soleno Therapeutics Inc
12:03pm, Thursday, 03'rd Oct 2024
On September 30, 2024, Janus Henderson Group PLC, a prominent investment firm, significantly increased its stake in Soleno Therapeutics Inc (SLNO, Financial) by acquiring an additional 804,805 shares.
Soleno Therapeutics to Present at 2024 Cantor Global Healthcare Conference
04:05pm, Monday, 16'th Sep 2024
REDWOOD CITY, Calif., Sept. 16, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treat
Soleno Stock Up as FDA Accepts PWS Drug NDA Under Priority Review
11:25am, Wednesday, 28'th Aug 2024
SLNO stock gains 6.3% as FDA accepts regulatory filing for lead candidate, DCCR, to treat hyperphagia associated with PWS under Priority Review.
Soleno Therapeutics: 2 New Catalysts To Bring Forth Change For PWS Patients
01:00pm, Tuesday, 27'th Aug 2024
Soleno Therapeutics, Inc.'s NDA submission of DCCR for the treatment of patients with PWS accepted by the FDA with Priority Review with a PDUFA date of December 27th of 2024. Before the FDA PDUFA date
PDUFA target action date set for December 27, 2024 FDA currently plans to hold an Advisory Committee meeting REDWOOD CITY, Calif., Aug. 27, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Solen
Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:17pm, Monday, 19'th Aug 2024
REDWOOD CITY, Calif., Aug. 19, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatm
REDWOOD CITY, Calif., June 28, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatm
Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05:18pm, Monday, 24'th Jun 2024
REDWOOD CITY, Calif., June 24, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatm
PHILADELPHIA, PA / ACCESSWIRE / June 11, 2024 / Kaskela Law LLC announces that it is investigating Soleno Therapeutics, Inc. (NASDAQ:SLNO) ("Soleno") on behalf of the company's stockholders. The inves
3 Stocks That Have Seen Higher Share Gains Than Super Micro Computer
04:18pm, Thursday, 06'th Jun 2024
One of the stocks to benefit the most from the artificial intelligence (AI) craze has been Super Micro Computer (Nasdaq: SMCI).
REDWOOD CITY, Calif., May 22, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatme
Soleno Therapeutics to Participate in Upcoming Investor Conferences
08:00am, Wednesday, 22'nd May 2024
REDWOOD CITY, Calif., May 22, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatme
